Augmedics Strengthens AR/AI Portfolio With Planned Acquisition of Surgalign Digital Health Assets
Summary
The news comes a month following Augmedics’ $82.5 million raise to accelerate the adoption of augmented reality spine surgery and further strengthens the company’s AR and AI portfolio with intellectual property and other digital health assets. “We are pleased to further expand our strong technical and intellectual property position in the field of augmented reality surgery with this planned acquisition,” said Augmedics President & CEO Kevin Hykes. “Augmedics shares Surgalign’s passion for developing cutting-edge technology in the name of improved surgical outcomes. We look forward to leveraging these assets to further evolve the xvision platform.” The sale will close pending approval by the Bankruptcy Court at a hearing set for August 8, 2023. xvision has consistently demonstrated 97-100% accuracy of pedicle screw placement across multiple patient studies.